Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:30 PM
Ignite Modification Date:
2025-12-24 @ 1:30 PM
NCT ID:
NCT02327195
Eligibility Criteria:
Inclusion Criteria:
* Male or female, 18 to 65 years of age
* ASA I or II
* Capable and willing to consent
* Participants literate in English language
Exclusion Criteria:
* ADHD with current use of methylphenidate
* Hypersensitivity to methylphenidate
* ASA III, IV or V
* Patients with severe visual or auditory disorder
* Illiteracy
* Presence of a clinically diagnosed anxiety, agitation, major psychiatric condition such as bipolar disorder, uncontrolled major depression, schizophrenia
* Tics or Tourette's syndrome
* Glaucoma
* Hypertension, history of atrial arrhythmias (atrial fibrillation, atrial flutter), myocardial infarction
* Taking or have taken within the past 14 days a monoamine oxidase inhibitor or MAOI (Selegiline)
* Subjects who have participated or are currently participating in a clinical trial of an investigational drug within 30 days prior to surgery
* Any condition, which in the opinion of the investigator would make subject ineligible for participation in the study such as history of unstable cardiovascular, pulmonary, renal, hepatic, neurologic (seizures), hematologic or endocrine abnormality (hyperthyroidism, unstable Diabetes type I/II)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT02327195
Study Brief:
Protocol Section:
NCT02327195